nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Valrubicin—urinary bladder cancer	0.496	0.647	CbGbCtD
Norfloxacin—TOP2A—Epirubicin—urinary bladder cancer	0.0752	0.098	CbGbCtD
Norfloxacin—TOP2A—Etoposide—urinary bladder cancer	0.0586	0.0764	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—urinary bladder cancer	0.0399	0.0521	CbGbCtD
Norfloxacin—CYP2A6—Fluorouracil—urinary bladder cancer	0.0281	0.0367	CbGbCtD
Norfloxacin—CYP3A4—Thiotepa—urinary bladder cancer	0.0173	0.0226	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—urinary bladder cancer	0.012	0.0157	CbGbCtD
Norfloxacin—SLC22A6—Methotrexate—urinary bladder cancer	0.0116	0.0152	CbGbCtD
Norfloxacin—CYP1A2—Fluorouracil—urinary bladder cancer	0.0107	0.014	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—urinary bladder cancer	0.00896	0.0117	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—urinary bladder cancer	0.00469	0.00612	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0032	0.00418	CbGbCtD
Norfloxacin—CYP1A2—urine—urinary bladder cancer	0.00174	0.111	CbGeAlD
Norfloxacin—TOP2A—prostate gland—urinary bladder cancer	0.0013	0.083	CbGeAlD
Norfloxacin—CYP3A4—urine—urinary bladder cancer	0.00126	0.0803	CbGeAlD
Norfloxacin—CYP2A6—prostate gland—urinary bladder cancer	0.00119	0.0758	CbGeAlD
Norfloxacin—CYP2A6—seminal vesicle—urinary bladder cancer	0.00101	0.0641	CbGeAlD
Norfloxacin—SLC22A5—prostate gland—urinary bladder cancer	0.000689	0.0439	CbGeAlD
Norfloxacin—TOP2A—vagina—urinary bladder cancer	0.000642	0.041	CbGeAlD
Norfloxacin—CYP3A5—prostate gland—urinary bladder cancer	0.000602	0.0384	CbGeAlD
Norfloxacin—CYP2A6—vagina—urinary bladder cancer	0.000587	0.0374	CbGeAlD
Norfloxacin—SLC22A5—seminal vesicle—urinary bladder cancer	0.000583	0.0372	CbGeAlD
Norfloxacin—TOP2A—Daunorubicin—Valrubicin—urinary bladder cancer	0.000544	0.125	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Valrubicin—urinary bladder cancer	0.000544	0.125	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Valrubicin—urinary bladder cancer	0.000544	0.125	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Valrubicin—urinary bladder cancer	0.000544	0.125	CbGdCrCtD
Norfloxacin—SLC22A5—renal system—urinary bladder cancer	0.00047	0.0299	CbGeAlD
Norfloxacin—SLC22A5—urethra—urinary bladder cancer	0.000461	0.0294	CbGeAlD
Norfloxacin—CYP1A1—epithelium—urinary bladder cancer	0.000452	0.0288	CbGeAlD
Norfloxacin—CYP1A2—renal system—urinary bladder cancer	0.000425	0.0271	CbGeAlD
Norfloxacin—CYP1A1—renal system—urinary bladder cancer	0.00042	0.0268	CbGeAlD
Norfloxacin—TOP2A—lymph node—urinary bladder cancer	0.000415	0.0265	CbGeAlD
Norfloxacin—CYP1A1—urethra—urinary bladder cancer	0.000412	0.0263	CbGeAlD
Norfloxacin—CYP3A5—renal system—urinary bladder cancer	0.00041	0.0262	CbGeAlD
Norfloxacin—SLC22A5—female reproductive system—urinary bladder cancer	0.000376	0.024	CbGeAlD
Norfloxacin—TOP2A—Podofilox—Etoposide—urinary bladder cancer	0.000363	0.0835	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—urinary bladder cancer	0.000363	0.0835	CbGdCrCtD
Norfloxacin—SLC22A5—vagina—urinary bladder cancer	0.00034	0.0217	CbGeAlD
Norfloxacin—CYP1A1—female reproductive system—urinary bladder cancer	0.000336	0.0214	CbGeAlD
Norfloxacin—CYP3A4—renal system—urinary bladder cancer	0.000308	0.0196	CbGeAlD
Norfloxacin—CYP1A1—vagina—urinary bladder cancer	0.000304	0.0194	CbGeAlD
Norfloxacin—CYP3A5—vagina—urinary bladder cancer	0.000297	0.019	CbGeAlD
Norfloxacin—CYP3A4—female reproductive system—urinary bladder cancer	0.000247	0.0157	CbGeAlD
Norfloxacin—SLC22A5—lymph node—urinary bladder cancer	0.00022	0.014	CbGeAlD
Norfloxacin—TOP2A—Cytarabine—Gemcitabine—urinary bladder cancer	0.000204	0.047	CbGdCrCtD
Norfloxacin—CYP1A1—lymph node—urinary bladder cancer	0.000197	0.0125	CbGeAlD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—urinary bladder cancer	0.000189	0.0436	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—urinary bladder cancer	0.000189	0.0436	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—urinary bladder cancer	0.000189	0.0436	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000175	0.0403	CbGdCrCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—urinary bladder cancer	0.000175	0.0403	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—urinary bladder cancer	0.000175	0.0403	CbGdCrCtD
Norfloxacin—TOP2A—Azacitidine—Gemcitabine—urinary bladder cancer	0.000146	0.0337	CbGdCrCtD
Norfloxacin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000146	0.00103	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—urinary bladder cancer	0.000146	0.00103	CcSEcCtD
Norfloxacin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000146	0.00103	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000146	0.00103	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000145	0.00102	CcSEcCtD
Norfloxacin—Anorexia—Etoposide—urinary bladder cancer	0.000144	0.00101	CcSEcCtD
Norfloxacin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000144	0.00101	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000144	0.00101	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000144	0.00101	CcSEcCtD
Norfloxacin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000143	0.00101	CcSEcCtD
Norfloxacin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000143	0.00101	CcSEcCtD
Norfloxacin—Drowsiness—Methotrexate—urinary bladder cancer	0.000142	0.001	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000141	0.000991	CcSEcCtD
Norfloxacin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00014	0.000986	CcSEcCtD
Norfloxacin—Renal failure—Methotrexate—urinary bladder cancer	0.00014	0.000983	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—urinary bladder cancer	0.000139	0.000981	CcSEcCtD
Norfloxacin—Dizziness—Thiotepa—urinary bladder cancer	0.000139	0.00098	CcSEcCtD
Norfloxacin—Stomatitis—Methotrexate—urinary bladder cancer	0.000138	0.000975	CcSEcCtD
Norfloxacin—Urticaria—Fluorouracil—urinary bladder cancer	0.000138	0.000974	CcSEcCtD
Norfloxacin—Conjunctivitis—Methotrexate—urinary bladder cancer	0.000138	0.000972	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—urinary bladder cancer	0.000138	0.000971	CcSEcCtD
Norfloxacin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000138	0.000969	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000137	0.000961	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000136	0.000958	CcSEcCtD
Norfloxacin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000136	0.000958	CcSEcCtD
Norfloxacin—Paraesthesia—Etoposide—urinary bladder cancer	0.000136	0.000956	CcSEcCtD
Norfloxacin—Haematuria—Methotrexate—urinary bladder cancer	0.000135	0.000953	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000135	0.000952	CcSEcCtD
Norfloxacin—Dyspnoea—Etoposide—urinary bladder cancer	0.000135	0.000949	CcSEcCtD
Norfloxacin—Somnolence—Etoposide—urinary bladder cancer	0.000134	0.000946	CcSEcCtD
Norfloxacin—Vomiting—Thiotepa—urinary bladder cancer	0.000134	0.000942	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—urinary bladder cancer	0.000133	0.000936	CcSEcCtD
Norfloxacin—Rash—Thiotepa—urinary bladder cancer	0.000133	0.000934	CcSEcCtD
Norfloxacin—Dermatitis—Thiotepa—urinary bladder cancer	0.000133	0.000934	CcSEcCtD
Norfloxacin—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000133	0.000933	CcSEcCtD
Norfloxacin—Headache—Thiotepa—urinary bladder cancer	0.000132	0.000928	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000132	0.000928	CcSEcCtD
Norfloxacin—Decreased appetite—Etoposide—urinary bladder cancer	0.000131	0.000925	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—urinary bladder cancer	0.000131	0.00092	CcSEcCtD
Norfloxacin—Body temperature increased—Cisplatin—urinary bladder cancer	0.00013	0.000919	CcSEcCtD
Norfloxacin—Fatigue—Etoposide—urinary bladder cancer	0.00013	0.000918	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.00013	0.000917	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—urinary bladder cancer	0.00013	0.000912	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—urinary bladder cancer	0.00013	0.000912	CcSEcCtD
Norfloxacin—Constipation—Etoposide—urinary bladder cancer	0.000129	0.00091	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000129	0.00091	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—urinary bladder cancer	0.000129	0.000908	CcSEcCtD
Norfloxacin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000128	0.000903	CcSEcCtD
Norfloxacin—Hepatitis—Methotrexate—urinary bladder cancer	0.000127	0.000898	CcSEcCtD
Norfloxacin—Asthenia—Gemcitabine—urinary bladder cancer	0.000127	0.000895	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—urinary bladder cancer	0.000127	0.000892	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000126	0.000886	CcSEcCtD
Norfloxacin—Pruritus—Gemcitabine—urinary bladder cancer	0.000125	0.000882	CcSEcCtD
Norfloxacin—Nausea—Thiotepa—urinary bladder cancer	0.000125	0.00088	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000125	0.000877	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000124	0.000873	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000124	0.000871	CcSEcCtD
Norfloxacin—Pruritus—Fluorouracil—urinary bladder cancer	0.000123	0.000867	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000123	0.000866	CcSEcCtD
Norfloxacin—Visual impairment—Methotrexate—urinary bladder cancer	0.000123	0.000865	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000122	0.000858	CcSEcCtD
Norfloxacin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000122	0.000856	CcSEcCtD
Norfloxacin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000121	0.000853	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—urinary bladder cancer	0.000121	0.000851	CcSEcCtD
Norfloxacin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000121	0.000849	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000121	0.000849	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—urinary bladder cancer	0.00012	0.000846	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—urinary bladder cancer	0.00012	0.000844	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—urinary bladder cancer	0.00012	0.000844	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—urinary bladder cancer	0.00012	0.000842	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—urinary bladder cancer	0.00012	0.000842	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00012	0.000842	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—urinary bladder cancer	0.000119	0.00084	CcSEcCtD
Norfloxacin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000119	0.000839	CcSEcCtD
Norfloxacin—Tinnitus—Methotrexate—urinary bladder cancer	0.000119	0.000837	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000119	0.000836	CcSEcCtD
Norfloxacin—Asthenia—Cisplatin—urinary bladder cancer	0.000118	0.000834	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—urinary bladder cancer	0.000117	0.000825	CcSEcCtD
Norfloxacin—Dizziness—Fluorouracil—urinary bladder cancer	0.000115	0.000811	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—urinary bladder cancer	0.000115	0.000809	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000115	0.000808	CcSEcCtD
Norfloxacin—Chills—Methotrexate—urinary bladder cancer	0.000114	0.000805	CcSEcCtD
Norfloxacin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000113	0.000795	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000113	0.000794	CcSEcCtD
Norfloxacin—Vomiting—Gemcitabine—urinary bladder cancer	0.000113	0.000793	CcSEcCtD
Norfloxacin—Rash—Gemcitabine—urinary bladder cancer	0.000112	0.000786	CcSEcCtD
Norfloxacin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000112	0.000785	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000111	0.000784	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—urinary bladder cancer	0.000111	0.000783	CcSEcCtD
Norfloxacin—Erythema—Methotrexate—urinary bladder cancer	0.000111	0.000781	CcSEcCtD
Norfloxacin—Headache—Gemcitabine—urinary bladder cancer	0.000111	0.000781	CcSEcCtD
Norfloxacin—Vomiting—Fluorouracil—urinary bladder cancer	0.000111	0.000779	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—urinary bladder cancer	0.00011	0.000777	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00011	0.000773	CcSEcCtD
Norfloxacin—Rash—Fluorouracil—urinary bladder cancer	0.00011	0.000773	CcSEcCtD
Norfloxacin—Dermatitis—Fluorouracil—urinary bladder cancer	0.00011	0.000772	CcSEcCtD
Norfloxacin—Headache—Fluorouracil—urinary bladder cancer	0.000109	0.000768	CcSEcCtD
Norfloxacin—Dysgeusia—Methotrexate—urinary bladder cancer	0.000109	0.000765	CcSEcCtD
Norfloxacin—Asthenia—Etoposide—urinary bladder cancer	0.000108	0.000764	CcSEcCtD
Norfloxacin—Back pain—Methotrexate—urinary bladder cancer	0.000107	0.000756	CcSEcCtD
Norfloxacin—Chills—Epirubicin—urinary bladder cancer	0.000107	0.000754	CcSEcCtD
Norfloxacin—Pruritus—Etoposide—urinary bladder cancer	0.000107	0.000753	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000106	0.000749	CcSEcCtD
Norfloxacin—Nausea—Gemcitabine—urinary bladder cancer	0.000105	0.000741	CcSEcCtD
Norfloxacin—Vomiting—Cisplatin—urinary bladder cancer	0.000105	0.000739	CcSEcCtD
Norfloxacin—Vision blurred—Methotrexate—urinary bladder cancer	0.000105	0.000736	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000104	0.000735	CcSEcCtD
Norfloxacin—Rash—Cisplatin—urinary bladder cancer	0.000104	0.000733	CcSEcCtD
Norfloxacin—Dermatitis—Cisplatin—urinary bladder cancer	0.000104	0.000732	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—urinary bladder cancer	0.000104	0.000731	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—urinary bladder cancer	0.000103	0.000728	CcSEcCtD
Norfloxacin—Nausea—Fluorouracil—urinary bladder cancer	0.000103	0.000728	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000103	0.000725	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—urinary bladder cancer	0.000102	0.000721	CcSEcCtD
Norfloxacin—Tension—Epirubicin—urinary bladder cancer	0.000102	0.000718	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—urinary bladder cancer	0.000102	0.000716	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—urinary bladder cancer	0.000101	0.00071	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—urinary bladder cancer	0.0001	0.000707	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—urinary bladder cancer	0.0001	0.000704	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—urinary bladder cancer	9.98e-05	0.000703	CcSEcCtD
Norfloxacin—Vertigo—Methotrexate—urinary bladder cancer	9.97e-05	0.000702	CcSEcCtD
Norfloxacin—Leukopenia—Methotrexate—urinary bladder cancer	9.93e-05	0.000699	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—urinary bladder cancer	9.9e-05	0.000697	CcSEcCtD
Norfloxacin—Nausea—Cisplatin—urinary bladder cancer	9.8e-05	0.00069	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—urinary bladder cancer	9.79e-05	0.000689	CcSEcCtD
Norfloxacin—Convulsion—Methotrexate—urinary bladder cancer	9.61e-05	0.000677	CcSEcCtD
Norfloxacin—Vomiting—Etoposide—urinary bladder cancer	9.61e-05	0.000677	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—urinary bladder cancer	9.61e-05	0.000677	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—urinary bladder cancer	9.54e-05	0.000672	CcSEcCtD
Norfloxacin—Rash—Etoposide—urinary bladder cancer	9.53e-05	0.000671	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—urinary bladder cancer	9.52e-05	0.000671	CcSEcCtD
Norfloxacin—Headache—Etoposide—urinary bladder cancer	9.47e-05	0.000667	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—urinary bladder cancer	9.47e-05	0.000667	CcSEcCtD
Norfloxacin—Arthralgia—Methotrexate—urinary bladder cancer	9.45e-05	0.000665	CcSEcCtD
Norfloxacin—Chest pain—Methotrexate—urinary bladder cancer	9.45e-05	0.000665	CcSEcCtD
Norfloxacin—Myalgia—Methotrexate—urinary bladder cancer	9.45e-05	0.000665	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—urinary bladder cancer	9.43e-05	0.000664	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—urinary bladder cancer	9.41e-05	0.000663	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—urinary bladder cancer	9.33e-05	0.000657	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—urinary bladder cancer	9.33e-05	0.000657	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—urinary bladder cancer	9.3e-05	0.000655	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—urinary bladder cancer	9.29e-05	0.000654	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—urinary bladder cancer	9.24e-05	0.00065	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—urinary bladder cancer	9.18e-05	0.000646	CcSEcCtD
Norfloxacin—Confusional state—Methotrexate—urinary bladder cancer	9.13e-05	0.000643	CcSEcCtD
Norfloxacin—Anaphylactic shock—Methotrexate—urinary bladder cancer	9.06e-05	0.000638	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—urinary bladder cancer	9.06e-05	0.000638	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—urinary bladder cancer	9e-05	0.000634	CcSEcCtD
Norfloxacin—Nausea—Etoposide—urinary bladder cancer	8.98e-05	0.000632	CcSEcCtD
Norfloxacin—Thrombocytopenia—Methotrexate—urinary bladder cancer	8.87e-05	0.000624	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—urinary bladder cancer	8.84e-05	0.000623	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—urinary bladder cancer	8.84e-05	0.000623	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—urinary bladder cancer	8.84e-05	0.000623	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—urinary bladder cancer	8.83e-05	0.000622	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—urinary bladder cancer	8.81e-05	0.00062	CcSEcCtD
Norfloxacin—Hyperhidrosis—Methotrexate—urinary bladder cancer	8.75e-05	0.000616	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—urinary bladder cancer	8.65e-05	0.000609	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—urinary bladder cancer	8.63e-05	0.000608	CcSEcCtD
Norfloxacin—Anorexia—Methotrexate—urinary bladder cancer	8.63e-05	0.000608	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—urinary bladder cancer	8.6e-05	0.000606	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—urinary bladder cancer	8.55e-05	0.000602	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—urinary bladder cancer	8.49e-05	0.000598	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—urinary bladder cancer	8.47e-05	0.000597	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—urinary bladder cancer	8.47e-05	0.000597	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—urinary bladder cancer	8.32e-05	0.000586	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—urinary bladder cancer	8.3e-05	0.000584	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	8.25e-05	0.000581	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—urinary bladder cancer	8.19e-05	0.000577	CcSEcCtD
Norfloxacin—Insomnia—Methotrexate—urinary bladder cancer	8.19e-05	0.000577	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—urinary bladder cancer	8.18e-05	0.000576	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—urinary bladder cancer	8.18e-05	0.000576	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—urinary bladder cancer	8.18e-05	0.000576	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—urinary bladder cancer	8.15e-05	0.000574	CcSEcCtD
Norfloxacin—Paraesthesia—Methotrexate—urinary bladder cancer	8.13e-05	0.000573	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—urinary bladder cancer	8.08e-05	0.000569	CcSEcCtD
Norfloxacin—Dyspnoea—Methotrexate—urinary bladder cancer	8.07e-05	0.000569	CcSEcCtD
Norfloxacin—Somnolence—Methotrexate—urinary bladder cancer	8.05e-05	0.000567	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—urinary bladder cancer	8e-05	0.000563	CcSEcCtD
Norfloxacin—Dyspepsia—Methotrexate—urinary bladder cancer	7.97e-05	0.000561	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—urinary bladder cancer	7.91e-05	0.000557	CcSEcCtD
Norfloxacin—Decreased appetite—Methotrexate—urinary bladder cancer	7.87e-05	0.000554	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.84e-05	0.000552	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—urinary bladder cancer	7.84e-05	0.000552	CcSEcCtD
Norfloxacin—Fatigue—Methotrexate—urinary bladder cancer	7.81e-05	0.00055	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	7.72e-05	0.000544	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—urinary bladder cancer	7.68e-05	0.000541	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—urinary bladder cancer	7.67e-05	0.00054	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—urinary bladder cancer	7.61e-05	0.000536	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	7.58e-05	0.000534	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—urinary bladder cancer	7.56e-05	0.000532	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—urinary bladder cancer	7.53e-05	0.000531	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—urinary bladder cancer	7.47e-05	0.000526	CcSEcCtD
Norfloxacin—Feeling abnormal—Methotrexate—urinary bladder cancer	7.46e-05	0.000525	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—urinary bladder cancer	7.46e-05	0.000525	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.41e-05	0.000521	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—urinary bladder cancer	7.37e-05	0.000519	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—urinary bladder cancer	7.31e-05	0.000514	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—urinary bladder cancer	7.25e-05	0.00051	CcSEcCtD
Norfloxacin—Urticaria—Methotrexate—urinary bladder cancer	7.19e-05	0.000507	CcSEcCtD
Norfloxacin—Body temperature increased—Methotrexate—urinary bladder cancer	7.16e-05	0.000504	CcSEcCtD
Norfloxacin—Abdominal pain—Methotrexate—urinary bladder cancer	7.16e-05	0.000504	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.14e-05	0.000503	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—urinary bladder cancer	7.09e-05	0.000499	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—urinary bladder cancer	7.04e-05	0.000496	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—urinary bladder cancer	6.99e-05	0.000492	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—urinary bladder cancer	6.98e-05	0.000492	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—urinary bladder cancer	6.97e-05	0.000491	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.93e-05	0.000488	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—urinary bladder cancer	6.9e-05	0.000486	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—urinary bladder cancer	6.82e-05	0.00048	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—urinary bladder cancer	6.76e-05	0.000476	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—urinary bladder cancer	6.73e-05	0.000474	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—urinary bladder cancer	6.71e-05	0.000472	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—urinary bladder cancer	6.7e-05	0.000472	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—urinary bladder cancer	6.7e-05	0.000472	CcSEcCtD
Norfloxacin—Hypersensitivity—Methotrexate—urinary bladder cancer	6.67e-05	0.00047	CcSEcCtD
Norfloxacin—Asthenia—Methotrexate—urinary bladder cancer	6.5e-05	0.000458	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—urinary bladder cancer	6.46e-05	0.000455	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.41e-05	0.000452	CcSEcCtD
Norfloxacin—Pruritus—Methotrexate—urinary bladder cancer	6.41e-05	0.000451	CcSEcCtD
Norfloxacin—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.3e-05	0.000883	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Epirubicin—urinary bladder cancer	6.24e-05	0.00044	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—urinary bladder cancer	6.23e-05	0.000439	CcSEcCtD
Norfloxacin—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	6.22e-05	0.000871	CbGpPWpGaD
Norfloxacin—Abdominal pain—Doxorubicin—urinary bladder cancer	6.2e-05	0.000436	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—urinary bladder cancer	6.2e-05	0.000436	CcSEcCtD
Norfloxacin—Diarrhoea—Methotrexate—urinary bladder cancer	6.2e-05	0.000436	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—PTEN—urinary bladder cancer	6.18e-05	0.000866	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.14e-05	0.000861	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.13e-05	0.000859	CbGpPWpGaD
Norfloxacin—Asthenia—Epirubicin—urinary bladder cancer	6.08e-05	0.000428	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	6.06e-05	0.00085	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	6.06e-05	0.000849	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	6.02e-05	0.000843	CbGpPWpGaD
Norfloxacin—Pruritus—Epirubicin—urinary bladder cancer	6e-05	0.000422	CcSEcCtD
Norfloxacin—Dizziness—Methotrexate—urinary bladder cancer	5.99e-05	0.000422	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	5.97e-05	0.000837	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—EP300—urinary bladder cancer	5.9e-05	0.000826	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	5.89e-05	0.000825	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	5.88e-05	0.000824	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	5.87e-05	0.000823	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	5.85e-05	0.00082	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCNE1—urinary bladder cancer	5.84e-05	0.000819	CbGpPWpGaD
Norfloxacin—Diarrhoea—Epirubicin—urinary bladder cancer	5.8e-05	0.000408	CcSEcCtD
Norfloxacin—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.79e-05	0.000812	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	5.78e-05	0.00081	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.78e-05	0.000407	CcSEcCtD
Norfloxacin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	5.77e-05	0.000809	CbGpPWpGaD
Norfloxacin—Vomiting—Methotrexate—urinary bladder cancer	5.76e-05	0.000405	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle—TYMS—urinary bladder cancer	5.74e-05	0.000804	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	5.73e-05	0.000803	CbGpPWpGaD
Norfloxacin—Rash—Methotrexate—urinary bladder cancer	5.71e-05	0.000402	CcSEcCtD
Norfloxacin—Dermatitis—Methotrexate—urinary bladder cancer	5.7e-05	0.000402	CcSEcCtD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	5.67e-05	0.000795	CbGpPWpGaD
Norfloxacin—Headache—Methotrexate—urinary bladder cancer	5.67e-05	0.000399	CcSEcCtD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	5.66e-05	0.000794	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	5.66e-05	0.000793	CbGpPWpGaD
Norfloxacin—Asthenia—Doxorubicin—urinary bladder cancer	5.63e-05	0.000396	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	5.62e-05	0.000788	CbGpPWpGaD
Norfloxacin—Dizziness—Epirubicin—urinary bladder cancer	5.6e-05	0.000395	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—urinary bladder cancer	5.55e-05	0.000391	CcSEcCtD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.53e-05	0.000775	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	5.44e-05	0.000762	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NAT1—urinary bladder cancer	5.44e-05	0.000762	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	5.41e-05	0.000759	CbGpPWpGaD
Norfloxacin—Vomiting—Epirubicin—urinary bladder cancer	5.39e-05	0.000379	CcSEcCtD
Norfloxacin—Nausea—Methotrexate—urinary bladder cancer	5.38e-05	0.000379	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—urinary bladder cancer	5.37e-05	0.000378	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.35e-05	0.00075	CbGpPWpGaD
Norfloxacin—Rash—Epirubicin—urinary bladder cancer	5.34e-05	0.000376	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—urinary bladder cancer	5.34e-05	0.000376	CcSEcCtD
Norfloxacin—Headache—Epirubicin—urinary bladder cancer	5.31e-05	0.000374	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	5.3e-05	0.000743	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTZ1—urinary bladder cancer	5.26e-05	0.000736	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.24e-05	0.000734	CbGpPWpGaD
Norfloxacin—Dizziness—Doxorubicin—urinary bladder cancer	5.19e-05	0.000365	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	5.04e-05	0.000707	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	5.04e-05	0.000707	CbGpPWpGaD
Norfloxacin—Nausea—Epirubicin—urinary bladder cancer	5.03e-05	0.000354	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	5e-05	0.000701	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TERT—urinary bladder cancer	5e-05	0.0007	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	4.99e-05	0.000699	CbGpPWpGaD
Norfloxacin—Vomiting—Doxorubicin—urinary bladder cancer	4.99e-05	0.000351	CcSEcCtD
Norfloxacin—CYP2A6—Metabolism—GSTO2—urinary bladder cancer	4.98e-05	0.000698	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NAT1—urinary bladder cancer	4.98e-05	0.000698	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	4.97e-05	0.000697	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	4.95e-05	0.000693	CbGpPWpGaD
Norfloxacin—Rash—Doxorubicin—urinary bladder cancer	4.94e-05	0.000348	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—urinary bladder cancer	4.94e-05	0.000348	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—urinary bladder cancer	4.91e-05	0.000346	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	4.9e-05	0.000687	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	4.9e-05	0.000687	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	4.68e-05	0.000656	CbGpPWpGaD
Norfloxacin—Nausea—Doxorubicin—urinary bladder cancer	4.66e-05	0.000328	CcSEcCtD
Norfloxacin—CYP2A6—Metabolism—UGT2B7—urinary bladder cancer	4.56e-05	0.000638	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	4.54e-05	0.000636	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—ATM—urinary bladder cancer	4.49e-05	0.000629	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	4.48e-05	0.000627	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK4—urinary bladder cancer	4.47e-05	0.000627	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.4e-05	0.000616	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	4.4e-05	0.000616	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	4.38e-05	0.000613	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	4.35e-05	0.00061	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	4.3e-05	0.000602	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	4.3e-05	0.000602	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	4.23e-05	0.000592	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—urinary bladder cancer	4.22e-05	0.000591	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	4.14e-05	0.000581	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	4.12e-05	0.000577	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	4.1e-05	0.000575	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	4.09e-05	0.000574	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	4.09e-05	0.000574	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	4.08e-05	0.000571	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	4.06e-05	0.000569	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	4.06e-05	0.000569	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.02e-05	0.000563	CbGpPWpGaD
Norfloxacin—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	3.94e-05	0.000552	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	3.93e-05	0.000551	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NAT1—urinary bladder cancer	3.93e-05	0.000551	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	3.92e-05	0.000549	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	3.9e-05	0.000546	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—RB1—urinary bladder cancer	3.89e-05	0.000545	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	3.87e-05	0.000543	CbGpPWpGaD
Norfloxacin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	3.85e-05	0.00054	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	3.82e-05	0.000536	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	3.78e-05	0.000529	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	3.75e-05	0.000525	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	3.71e-05	0.00052	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NAT1—urinary bladder cancer	3.71e-05	0.00052	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.69e-05	0.000518	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.65e-05	0.000512	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	3.59e-05	0.000504	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	3.45e-05	0.000484	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.43e-05	0.000481	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—urinary bladder cancer	3.42e-05	0.000479	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	3.4e-05	0.000476	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TYMP—urinary bladder cancer	3.29e-05	0.000461	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	3.24e-05	0.000453	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	3.23e-05	0.000453	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	3.15e-05	0.000441	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	3.13e-05	0.000438	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	3.1e-05	0.000435	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	3.06e-05	0.000428	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	3.06e-05	0.000428	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TYMP—urinary bladder cancer	3.02e-05	0.000423	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NAT2—urinary bladder cancer	2.98e-05	0.000417	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	2.98e-05	0.000417	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	2.97e-05	0.000417	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	2.89e-05	0.000405	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—urinary bladder cancer	2.89e-05	0.000405	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	2.89e-05	0.000404	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	2.85e-05	0.000399	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	2.81e-05	0.000394	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1A—urinary bladder cancer	2.79e-05	0.000392	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NAT2—urinary bladder cancer	2.73e-05	0.000382	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—EP300—urinary bladder cancer	2.66e-05	0.000373	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	2.66e-05	0.000372	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	2.59e-05	0.000363	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.59e-05	0.000363	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—RRM2—urinary bladder cancer	2.57e-05	0.00036	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	2.5e-05	0.00035	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ENO2—urinary bladder cancer	2.38e-05	0.000334	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	2.38e-05	0.000334	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TYMP—urinary bladder cancer	2.38e-05	0.000334	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	2.37e-05	0.000332	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	2.37e-05	0.000332	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—RRM2—urinary bladder cancer	2.36e-05	0.00033	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	2.33e-05	0.000326	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—urinary bladder cancer	2.32e-05	0.000325	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	2.31e-05	0.000324	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.26e-05	0.000316	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TYMP—urinary bladder cancer	2.25e-05	0.000315	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	2.18e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ENO2—urinary bladder cancer	2.18e-05	0.000306	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	2.16e-05	0.000303	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.16e-05	0.000303	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NAT2—urinary bladder cancer	2.15e-05	0.000302	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	2.12e-05	0.000297	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NAT2—urinary bladder cancer	2.03e-05	0.000285	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	1.95e-05	0.000273	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	1.93e-05	0.00027	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NQO1—urinary bladder cancer	1.92e-05	0.000269	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—urinary bladder cancer	1.9e-05	0.000267	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—RRM2—urinary bladder cancer	1.86e-05	0.00026	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	1.84e-05	0.000258	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	1.83e-05	0.000256	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	1.83e-05	0.000256	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	1.79e-05	0.000251	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NQO1—urinary bladder cancer	1.76e-05	0.000246	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—RRM2—urinary bladder cancer	1.76e-05	0.000246	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ENO2—urinary bladder cancer	1.72e-05	0.000241	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	1.72e-05	0.000241	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	1.67e-05	0.000234	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	1.67e-05	0.000234	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ENO2—urinary bladder cancer	1.63e-05	0.000228	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	1.63e-05	0.000228	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.62e-05	0.000226	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.6e-05	0.000224	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	1.58e-05	0.000221	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.55e-05	0.000218	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.5e-05	0.000211	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.49e-05	0.000208	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.47e-05	0.000206	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.47e-05	0.000206	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	1.47e-05	0.000206	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.44e-05	0.000202	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.43e-05	0.000201	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.42e-05	0.000199	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.41e-05	0.000197	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.39e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.38e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.38e-05	0.000194	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.38e-05	0.000193	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TYMS—urinary bladder cancer	1.36e-05	0.000191	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	1.35e-05	0.000189	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	1.35e-05	0.000189	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.31e-05	0.000184	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.3e-05	0.000182	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.3e-05	0.000182	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPX1—urinary bladder cancer	1.29e-05	0.000181	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.27e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	1.27e-05	0.000178	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	0.000167	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.16e-05	0.000162	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.12e-05	0.000157	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.11e-05	0.000155	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.11e-05	0.000155	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	0.000153	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.08e-05	0.000151	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	0.000149	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	0.000149	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.06e-05	0.000148	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.05e-05	0.000148	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.04e-05	0.000145	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.04e-05	0.000145	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.03e-05	0.000144	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.02e-05	0.000143	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.02e-05	0.000142	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.01e-05	0.000142	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.01e-05	0.000141	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1e-05	0.000141	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1e-05	0.000141	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1e-05	0.00014	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1e-05	0.00014	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.9e-06	0.000139	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPARG—urinary bladder cancer	9.66e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPX1—urinary bladder cancer	9.62e-06	0.000135	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	9.44e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	9.4e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	9.28e-06	0.00013	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	8.88e-06	0.000124	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	8.64e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.36e-06	0.000117	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	8.29e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.11e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	8e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	8e-06	0.000112	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	7.76e-06	0.000109	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPARG—urinary bladder cancer	7.62e-06	0.000107	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	7.6e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	7.32e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—urinary bladder cancer	7.23e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPARG—urinary bladder cancer	7.2e-06	0.000101	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.07e-06	9.91e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	6.97e-06	9.77e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	6.92e-06	9.69e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—EP300—urinary bladder cancer	6.9e-06	9.66e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.74e-06	9.45e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—urinary bladder cancer	6.63e-06	9.29e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.48e-06	9.08e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	6.45e-06	9.04e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.41e-06	8.97e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.41e-06	8.97e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—EP300—urinary bladder cancer	6.32e-06	8.86e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.13e-06	8.59e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.02e-06	8.44e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	5.99e-06	8.4e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	5.66e-06	7.93e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	5.66e-06	7.93e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	5.38e-06	7.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—urinary bladder cancer	5.23e-06	7.32e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	5e-06	7.01e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.99e-06	6.99e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.94e-06	6.93e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.94e-06	6.93e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—urinary bladder cancer	4.94e-06	6.92e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—EP300—urinary bladder cancer	4.71e-06	6.6e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	4.65e-06	6.51e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.59e-06	6.43e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.41e-06	6.18e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	4.37e-06	6.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.61e-06	5.06e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	3.54e-06	4.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	3.4e-06	4.77e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.15e-06	4.41e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—EP300—urinary bladder cancer	3e-06	4.21e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.79e-06	3.9e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	2.43e-06	3.41e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.32e-06	3.25e-05	CbGpPWpGaD
